Evidence map›Paper›PMID 32487048›Full record

ArticleBMC cancer2020

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.

Chuan Hu, Jiaxin Yang, Zhangheng Huang, Chuan Liu, Yijun Lin, Yuexin Tong, Zhiyi Fan, Bo Chen, Cailin Wang, Cheng-Liang Zhao

Abstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Prognositic value of anoikis and tumor immune microenvironment-related gene in the treatment of osteosarcoma.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chuan HuDepartment of Orthopedic, Affiliated Hospital of Chengde Medical University, No. 36 Nanyingzi St., Chengde, 067000, Hebei, China.
Jiaxin YangDepartment of Orthopedic, Affiliated Hospital of Chengde Medical University, No. 36 Nanyingzi St., Chengde, 067000, Hebei, China.
Zhangheng HuangDepartment of Orthopedic, Affiliated Hospital of Chengde Medical University, No. 36 Nanyingzi St., Chengde, 067000, Hebei, China.
Chuan LiuGraduate School of China Medical University, Liaoning, China.
Yijun LinSchool of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
Yuexin TongDepartment of Orthopedic, Affiliated Hospital of Chengde Medical University, No. 36 Nanyingzi St., Chengde, 067000, Hebei, China.
Zhiyi FanDepartment of Orthopedic, Affiliated Hospital of Chengde Medical University, No. 36 Nanyingzi St., Chengde, 067000, Hebei, China.
Bo ChenWenzhou Medical University, Wenzhou, China.
Cailin WangWenzhou Medical University, Wenzhou, China.
Cheng-Liang ZhaoDepartment of Orthopedic, Affiliated Hospital of Chengde Medical University, No. 36 Nanyingzi St., Chengde, 067000, Hebei, China. 38221965@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBone metastasis (BM) is one of the common sites of hepatocellular carcinoma (HCC), and the prognosis of BM patients is worse than patients without it. Our study aimed to identify predictors and prognostic factors of BM in HCC patients and develop two nomograms to quantify the risk of BM and the prognosis of HCC patients with BM.

methodsWe retrospectively reviewed the data of patients who were diagnosed as HCC between 2010 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) database. Independent predictors for BM from HCC patients were determined by the univariate and multivariate logistic regression analysis. Independent prognostic factors for HCC patients with BM were identified by univariate and multivariate Cox regression analysis. Two nomograms were established and evaluated by calibration curves, receiver operating characteristic (ROC) curve, and decision curve analysis (DCA).

resultsNine thousand and forty-seven patients were included. The independent risk factors of BM in newly diagnosed HCC patients are sex, grade, T stage, and N stage. The independent prognostic factors for HCC patients with BM are radiotherapy, chemotherapy, and lung metastasis. The AUC of diagnostic nomogram were 0.726 in the training set and 0.629 in the testing set. For the prognostic nomogram, the AUCs of 6-, 9-, and 12-months were 0.753, 0.799, and 0.732 in the training set and 0.698, 0.770, and 0.823 in the validation set. The calibration curve and DCA indicated the good performance of the nomogram.

conclusionsTwo nomograms were established to predict the incidence of BM in HCC patients and the prognosis of HCC patients with BM, respectively. Both nomograms have satisfactory accuracy, and clinical utility may benefit for clinical decision-making.

Indexed as

NomogramsAgedAge FactorsBone NeoplasmsCarcinoma, HepatocellularClinical Decision-MakingFeasibility StudiesFemaleHumansIncidenceKaplan-Meier EstimateLiver NeoplasmsMaleMiddle AgedNeoplasm StagingRetrospective StudiesBone metastasisHepatocellular carcinomaNomogramPrognosis

Identifiers

PMID32487048
PMCPMC7268752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.